Abselion appoints Dale Gordon as Chair
Dale brings more than 30 years’ experience across the life sciences sector, with a background spanning bioprocessing, company building, and board leadership
Dale brings more than 30 years’ experience across the life sciences sector, with a background spanning bioprocessing, company building, and board leadership
Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform
Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins
Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
New kit enables rapid, accurate titer measurement across broad range of IgG subclasses and species on Amperia platform
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development